# Effect of Targeting Upper Normal Serum Magnesium Levels on Norepinephrine Requirements in Septic Shock Patients

> **NCT07716956** · NA · RECRUITING · sponsor: **Alexandria University** · enrollment: 60 (estimated)

## Conditions studied

- Septic Shock
- Sepsis

## Interventions

- **DRUG:** magnesium sulfate
- **OTHER:** standard care treatment

## Key facts

- **NCT ID:** NCT07716956
- **Lead sponsor:** Alexandria University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-07-30
- **Primary completion:** 2027-04
- **Final completion:** 2027-07
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2026-10-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07716956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07716956, "Effect of Targeting Upper Normal Serum Magnesium Levels on Norepinephrine Requirements in Septic Shock Patients". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07716956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*